Results 221 to 230 of about 29,547 (250)

Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma

Cancer Control, 2017
Intrahepatic cholangiocarcinoma represents the second most common primary liver cancer and is increasing in incidence. Most patients are diagnosed at an advanced, nonsurgical stage and only about 1 in 5 cases are surgically resectable.
Yun Shin Chun, Milind Javle
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Intrahepatic cholangiocarcinoma in Korea

Journal of Hepato-Biliary-Pancreatic Surgery, 1999
We reviewed surgically treated patients with intrahepatic cholangiocarcinoma to evaluate the clinical and pathologic features of intrahepatic cholangiocarcinoma that may affect long-term survival in Korean patients with the disease. Between 1990 and 1997, 28 patients with intrahepatic cholangiocarcinoma underwent laparotomy.
H J, Kim, S S, Yun, K H, Jung, W H, Kwun, J H, Choi   +4 more
openaire   +2 more sources

Classification of intrahepatic cholangiocarcinoma

Abdominal Radiology
Cholangiocarcinoma is a heterogenous malignancy with various classifications based on location, morphological features, histological features, and actionable genetic mutations. Intrahepatic cholangiocarcinoma (ICC), which arises in and proximal to second order bile ducts, is the second most common primary liver malignancy after hepatocellular carcinoma.
Maria, El Homsi, Ahmad, Alkhasawneh, Hina, Arif-Tiwari, Ferenc, Czeyda-Pommersheim, Hala, Khasawneh, Andrea Siobhan, Kierans, Raj Mohan, Paspulati, Charanjeet, Singh   +7 more
openaire   +2 more sources

Intrahepatic Cholangiocarcinoma

Annals of Surgery, 2009
Nuzzo G, Giuliante F, Ardito F, Giovannini I   +3 more
  +9 more sources

Liver Resection for Intrahepatic Cholangiocarcinoma

Tumori Journal, 2005
Aims and Background Intrahepatic cholangiocarcinoma (IHCC) is the second most common primary liver cancer, representing 10% of all primary liver malignancies. Despite the increase in its incidence, this tumor remains extremely rare in Western countries and few reports detailing experience with surgical resection
Giuliante, Felice, Gauzolino, Riccardo, Vellone, Maria, Ardito, Francesco, Murazio, Marino, Nuzzo, Gennaro   +5 more
openaire   +3 more sources

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians

Ca-A Cancer Journal for Clinicians, 2023
Demetrios Moris, Manisha Palta, Charles Y Kim   +2 more
exaly  

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

Cancer Cell, 2022
Liangqing Dong, Hongwen Zhu, Shangli Cai   +2 more
exaly  

Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?

Hepatology, 2022
Gonzalo Sapisochin, Tommy Ivanics, Julie K Heimbach   +2 more
exaly  

Intrahepatic intraductal cholangiocarcinoma

Abdominal Imaging, 2004
J K, Han, J M, Lee
openaire   +2 more sources

Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives

Expert Opinion on Investigational Drugs, 2021
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi   +2 more
exaly